รังสีเคมีบำบัดใน Stage III Non-small cell lung cancer

Robinson LA, Wagner H, Ruckdeschet J. Treatment of stage IIIA non-small cell kung cancer. Chest 2009; 123-22-25-2205.

Ruckdeschet JC. Combined modality therapy of non- small cell lung cancer.Semin Oncol 997; 24: 429-439.

Furuse K, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiothrapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 1999; 17: 1692-2699.

Curran W, Scott C, Langer C, et al. Phase comparison of sequential vs concurrent chemoradiation for patients(pts) with unresected stage III non-small cell lung cancer (NSCLC): Initial report of Radiation Therapy Oncology Group (RTOG) 9410. Proc Am Soc Clin Oncol 2000; 18. Abstract and presentation 1891.

Curran WJ, Scott CB, Langer CJ, et al. Long-term benefit is observed in a phase Ill comparison of sequential vs concurrent chemoradiation for patients with unresected stage III NSCLC: RTOG 9410. Proc Am Soc Clin Oncol 2003; 22: 121. Abstract 2499.

Fournel P, Perol M, Gilles R, et al. A randomized phase III trial of sequential chemo-radiotherapy versus concurrent chemoradiotherapy in locally advanced non small cell lung cancer (NSCLC) (GLOT-GFPC NPC 95-01 study). Proc Am Soc 1. Clin Oncol 2001. Abstract 1246.

Mudad R, Ramsey M, Kovitz K, K, et al. Concomitant weekly docetaxel, cisplatin and radiation therapy in the treatment of locally advanced non-small cell lung cancer. a dose-finding study. Lung Cacner 2003; 39: 173-177.

Segawa Y, Ueoka H, kiura K, et al. A phase I/II study of docetaxel (TXT) and cisplatin (CDDP) with concurrent thoracic radiotherapy (RTR) for locally advanced non-small cell lung cancer (LA-NSCI.C). Proc Am Soc Clin Oncol 2000; 10: 108a. Abstract 1988.

Yamamoto N, Nakagawa K, Uezima H, et al. Phase I study of weekly chemotherapy of docetaxel (DOC) + cisplatin (CDDP) with concurrent thoracic radion therapy (TRT) for unresectable stage III non-small cell lung cancer (NSCLC): correlation between A1-acid-glycoprotein (AAG) and esophagitis. Proc Am Clin Oncol 2001; 20: 154b. Abstract 2766.

Wu H-G, Bang Y-J, Choi Ek, et al. Phase I study of weekly docetaxel and cisplatin concurrent with thoracic radiotherapy in stage III non-small-cell lung cancer. Int J Radiation Oncology Biol Phys 12002; 52: 15-80.

Keller SM, Sudeshna A, Wagner H, et al. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small cell lung cancer. N Engl J Med 2000; 343: 1217-1222.

Waller D, Fairlamb DJ, Gower N, et al. The Big Luing chemotherapy for all patients with non-small cell lung cancer (NSCLC). Preliminary results in the surgical setting. Proc Am Soc Clin Oncol 2003;22: 632. Abstract 2543.

Scaglioti GV, Roldano F, Tori V, V, et al. Randomized study of adjuvant chemotherapyfor completely ressected stage I, II, or IIIA non-small cell lung cancer. J Nati Cancer Inst 2003; 95: 1453-1461.

The International Adjuvant Lung Cancer Trial Colla- borative Group. Cisplatin-based adjuvant chenotherapy in patients with completely resected non-small cell lung cancer. N Engl J Med 2004; 350: 351-360.